Public-registry trials using AMB-05X that Eichor's radar has found — 1 trial. All data below is from public sources; Eichor is not affiliated with any sponsor.
| Trial | Sponsor | Condition | Phase | Sites |
| A Study to Evaluate Safety and Efficacy of AMB-05X Injections in Subjects With TGCT | AmMax Bio, Inc. | Pigmented Villonodular Synovitis | PHASE2 | 6 |
Eichor generates a preliminary site-risk snapshot — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →
